NFKB1 and neoplasm: Prior work demonstrating slowed tumor growth in the absence of host NF‐κB p50 largely utilized p50−/− mice, with only one study showing slowed colon cancer tumor progression in mice lacking p50 specifically in activated monocytes, macrophages, and neutrophils [15].